FOR THE RECORD - May 28, 2009
- Share via
Amgen: An article in Business on Wednesday about Amgen Inc. paying $50 million for the rights to develop and sell an experimental heart-failure drug said the company was based in Irvine. Amgen’s headquarters is in Thousand Oaks.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
